Judge Brian M. Cogan said in his ruling Tuesday that Curaleaf “publicly and repeatedly acknowledged” in its stock listing statement that the FDA had not yet approved its CBD products for any medical purpose.

JUDGEMENT

123117438266

 

Also see

Cogan_Oct-Nov2014_3-pgs-pdf-3

Judge: CBD company did not mislead investors